Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurotoxicology

• Publication date

  2008-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuro.2008.04.008PMID 18539332PMCID PMC2615238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotoxic Complications of Chemotherapy in Patients with Cancer

  2012cited by this paper
• Interventions for preventing neuropathy caused by cisplatin and related compounds.

  2007cited by this paper
• A phase I study of cisplatin, temozolomide and thalidomide in patients with malignant brain tumors.

  2007cited by this paper
• Alzheimer’s therapeutics

  2007cited by this paper
• Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study.

  2007cited by this paper
• The Rho-Associated Kinase Inhibitor Fasudil Hydrochloride Enhances Neural Regeneration after Axotomy in the Peripheral Nervous System

  2007cited by this paper
• Neurologic toxicities of cancer therapies

  2006cited by this paper
• Small, Nonpeptide p75NTR Ligands Induce Survival Signaling and Inhibit proNGF-Induced Death

  2006cited by this paper
• Protective Effect of Erythropoietin and Its Carbamylated Derivative in Experimental Cisplatin Peripheral Neurotoxicity

  2006cited by this paper
• Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes.

  2006cited by this paper
• Activation of Rho after traumatic brain injury and seizure in rats.

  2006cited by this paper
• Faculty Opinions recommendation of MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth.

  2005cited by this paper
• Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group

  2005cited by this paper
• ProNGF: a neurotrophic or an apoptotic molecule?

  2004cited by this paper
• The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor

  2004cited by this paper
• Activation of Rho in the injured axons following spinal cord injury

  2004cited by this paper
• Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases.

  2004cited by this paper
• Inactivation and activation of Ras by the neurotrophin receptor p75

  2004cited by this paper
• Abl Tyrosine Kinase Promotes Dendrogenesis by Inducing Actin Cytoskeletal Rearrangements in Cooperation with Rho Family Small GTPases in Hippocampal Neurons

  2004cited by this paper
• Neurotrophins and their receptors: A convergence point for many signalling pathways

  2003cited by this paper
• The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI

  2003cited by this paper
• Neurologic complications of cancer therapy.

  2003cited by this paper
• Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system

  2003cited by this paper
• Paclitaxel in cancer therapy

  2002cited by this paper
• Guanine nucleotide exchange factors for Rho GTPases: turning on the switch.

  2002cited by this paper
• Inactivation of intracellular Rho to stimulate axon growth and regeneration.

  2002cited by this paper
• Glutamate-induced δ-catenin redistribution and dissociation from postsynaptic receptor complexes

  2002influential reference
• Glutamate-induced delta-catenin redistribution and dissociation from postsynaptic receptor complexes.

  2002influential reference
• The many faces of p75NTR.

  2002cited by this paper
• Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea.

  2002cited by this paper
• Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia.

  2001cited by this paper
• Toxic leukoencephalopathy.

  2001cited by this paper
• Regulation of neurotrophin‐induced axonal responses via Rho GTPases

  2001cited by this paper
• A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons.

  2000cited by this paper
• Small GTPases Rac and Rho in the Maintenance of Dendritic Spines and Branches in Hippocampal Pyramidal Neurons

  2000cited by this paper
• Neurotrophins: neurotrophic modulation of neurite growth.

  2000cited by this paper
• Adenosine triphosphate-evoked currents in cultured dorsal root ganglion neurons obtained from rat embryos: desensitization kinetics and modulation of glutamate release.

  2000cited by this paper
• Neuropathy under chemotherapy.

  2000cited by this paper
• Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth.

  1999cited by this paper
• [Neurologic complications of chemotherapy].

  1999cited by this paper
• Nerve growth factor prevention of aged-rat sympathetic neuron injury by cisplatin, vincristine and taxol--in vitro explant study.

  1999cited by this paper
• Toxic leukoencephalopathy.

  1999cited by this paper
• Neurocognitive deficits in medulloblastoma survivors and white matter loss

  1999cited by this paper
• Molecular Dissection of the Rho-associated Protein Kinase (p160ROCK)-regulated Neurite Remodeling in Neuroblastoma N1E-115 Cells

  1998cited by this paper
• NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants.

  1998cited by this paper
• Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.

  1998cited by this paper
• Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

  1997cited by this paper
• Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity

  1995cited by this paper
• Xenografts of primary human prostatic carcinoma.

  1993cited by this paper
• Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate

  1992cited by this paper
• Neurologic complications of chemotherapy.

  1991cited by this paper
• Developments in neuronal cell culture

  1988influential reference
• The establishment of polarity by hippocampal neurons in culture

  1988cited by this paper
• MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum

  1987cited by this paper
• Differential Localization of MAP‐2 and Tau in Mammalian Neurons in Situ a

  1986cited by this paper
• Nerve growth factor attenuates neurotoxic effects of taxol on spinal cord-ganglion explants from fetal mice.

  1982cited by this paper

• Deciphering transcriptomic changes in chemobrain: a comprehensive review

  2025cites this paper
• Small-Molecule Trk Agonists: Where Do We Go from Here?

  2025cites this paper
• Designing nanozymes for in vivo applications

  2024cites this paper
• Dose‐dependent cranial irradiation associations with brain structures and neuropsychological outcomes in children with posterior fossa brain tumors

  2024cites this paper
• In vitro activities and mechanisms of action of anti-cancer molecules from African medicinal plants: a systematic review.

  2024cites this paper
• Emerging trends in organ-on-a-chip systems for drug screening

  2023cites this paper
• ROCK2 Inhibition: A Futuristic Approach for the Management of Alzheimer's Disease.

  2022cites this paper
• Calcitriol supplementation attenuates cisplatin-induced behavioral and cognitive impairments through up-regulation of BDNF in male rats.

  2022cites this paper
• Azoxystrobin Impairs Neuronal Migration and Induces ROS Dependent Apoptosis in Cortical Neurons

  2021influential citation
• Chemical and Green ZnO Nanoparticles ameliorated adverse effects of cisplatin on histological structure, antioxidant defense system and neurotrophins expression in rat hippocampus.

  2021cites this paper
• Sex-Specific Differences in Toxicity Following Systemic Paclitaxel Treatment and Localized Cardiac Radiotherapy

  2021cites this paper
• Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases

  2021cites this paper
• Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies

  2020cites this paper
• Molecular Profiling of Human Induced Pluripotent Stem Cell Derived Cells and Their Application for the Drug Safety Study.

  2020cites this paper
• Melatonin Reverses 10-Hydroxycamptothecin-Induced Apoptosis and Autophagy in Mouse Oocyte

  2020cites this paper
• Methotrexate induces astrocyte apoptosis by disrupting folate metabolism in the mouse juvenile central nervous system.

  2019cites this paper
• Paclitaxel induces sex-biased behavioral deficits and changes in gene expression in mouse prefrontal cortex.

  2019cites this paper
• Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents.

  2019cites this paper
• Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway

  2019cites this paper
• Antioxidant Effects of Satureja hortensis L. Attenuate the Anxiogenic Effect of Cisplatin in Rats

  2019cites this paper
• Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton

  2019cites this paper
• Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA–NF-κB

  2019cites this paper
• Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy

  2018cites this paper
• Chronic Treatment with Combined Chemotherapeutic Agents Affects Hippocampal Micromorphometry and Function in Mice, Independently of Neuroinflammation

  2018cites this paper
• Success stories of natural product-based hybrid molecules for multi-factorial diseases.

  2018cites this paper
• Chapter 15 – Best Practice in Toxicological Pathology

  2017cites this paper
• Rho GTPases as therapeutic targets in cancer (Review)

  2017cites this paper
• Effect of electroacupuncture on the mRNA and protein expression of Rho-A and Rho-associated kinase II in spinal cord injury rats

  2017cites this paper
• Neurotrophin Receptor Signaling as a Therapeutic Target for Huntington's Disease.

  2017cites this paper
• A small molecule p75NTR ligand normalizes signalling and reduces Huntington’s disease phenotypes in R6/2 and BACHD mice

  2016cites this paper
• Diffusion Tensor Imaging and Neurobehavioral Outcome in Children With Brain Tumors Treated With Chemotherapy

  2016cites this paper
• Targeted nano-delivery of novel omega-3 conjugate against hepatocellular carcinoma: Regulating COX-2/bcl-2 expression in an animal model.

  2016cites this paper
• Study on Synthesis, Characterization and Antiproliferative Activity of Novel Diisopropylphenyl Esters of Selected Fatty Acids.

  2016cites this paper
• The role of RhoA / ROCK singal pathway in cardiac rupture after infarction

  2016cites this paper
• Src Family Kinase Inhibitors and their Role in the Treatment of Traumatic Brain Injuries

  2016cites this paper
• In vitro evaluation of anticancer effect and neurotoxicity of Styrylpyrone derivative (SPD)

  2016cites this paper
• Attenuation of Cisplatin-Induced Neurotoxicity by Cyanidin, a Natural Inhibitor of ROS-Mediated Apoptosis in PC12 Cells

  2015cites this paper
• PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth

  2015cites this paper
• Harnessing the potential of pluripotent stem cells to develop novel platforms to study human motor neurons in vitro

  2015cites this paper
• In Vitro Model for Defining Neurotoxicity of Anticancer Agents

  2015cites this paper
• The p75 neurotrophin receptor: at the crossroad of neural repair and death

  2015influential citation
• Microtubule-depolymerizing agents potentiate anti-tumor immunity by stimulation of dendritic cells

  2015cites this paper
• Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR.

  2014cites this paper
• Neurological adverse drug reactions of anticancer drugs

  2014cites this paper
• Neurochemical characterization of primary sensory neurons in a rat model of bortezomic-induced peripheral neuropathy

  2014cites this paper
• A novel small‐molecule activator of procaspase‐3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts

  2014cites this paper
• Cisplatin Inhibits Hippocampal Cell Proliferation and Alters the Expression of Apoptotic Genes

  2014cites this paper
• Dynamic Nature of the p75 Neurotrophin Receptor in Response to Injury and Disease

  2014cites this paper
• Structural brain alterations in children an average of 5 years after surgery and chemotherapy for brain tumors

  2014cites this paper
• Paclitaxel induces neurotoxicity through endoplasmic reticulum stress.

  2013cites this paper
• Neurotoxicity of cancer chemotherapy☆

  2013cites this paper
• A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer’s mouse model

  2013cites this paper
• Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate.

  2013cites this paper
• Interleukin-6 and JAK2/STAT3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7TD1 multiple myeloma cells.

  2013cites this paper
• Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease

  2013cites this paper
• Impact of Physalis angulata on Methotrexate-Induced Neurotoxicity

  2013cites this paper
• Central Nervous System Injury and Neurobiobehavioral Function in Children With Brain Tumors: A Review of the Literature

  2013cites this paper
• Chapter 9 – Best Practice in Toxicological Pathology

  2013cites this paper
• The therapeutic potential of Rho GTPase intervention

  2013cites this paper
• Interleukin-6 and JAK 2 / STAT 3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7 TD 1 multiple myeloma cells

  2013cites this paper
• A small molecule p75NTR ligand protects neurogenesis after traumatic brain injury

  2013cites this paper
• Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells

  2012cites this paper
• Central Nervous System Injury, Neurocognitive and Quality of Life Outcomes in Children with Brain Tumors Treated with Chemotherapy

  2012influential citation
• Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro.

  2011cites this paper
• RHO GTPASAS COMO BLANCOS TERAPEUTICOS RELEVANTES EN CANCER Y OTRAS ENFERMEDADES HUMANAS

  2010cites this paper
• Evaluation of curcumin and cisplatin-induced DNA damage in PC12 cells by the alkaline comet assay

  2010cites this paper
• [Rho GTPases as therapeutic targets in cancer and other human diseases].

  2010cites this paper
• β-Arrestin 1 Inhibits the GTPase-Activating Protein Function of ARHGAP21, Promoting Activation of RhoA following Angiotensin II Type 1A Receptor Stimulation

  2010cites this paper
• Evaluation of curcumin and cisplatin-induced DNA damage in PC12 cells by the alkaline comet assay.

  2010cites this paper
• Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.

  2010cites this paper
• Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells.

  2010cites this paper
• Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.

  2010cites this paper
• Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain

  2009cites this paper
• Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration.

  2009cites this paper
• Isoalvaxanthone inhibits colon cancer cell proliferation, migration and invasion through inactivating Rac1 and AP‐1

  2009cites this paper
• Signaling through Rho GTPase pathway as viable drug target.

  2009influential citation